Eugia Pharma Receives USFDA Approval for Acetaminophen Injection 1,000 mg/100 mL Single-Dose Vials
Published: October 21, 2020
Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Acetaminophen Injection 1,000 mg/100 mL Single-Dose Vials.
Indications for this product include:
- Mild to moderate pain in adult and pediatric patients 2 years and older;
- Moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older;
- Reduction of fever in adult and pediatric patients.
Refer to package insert for full prescribing information including Boxed Warning.